Polycystic kidney disease- A case report

被引:0
作者
Aldali, Jehad A. [1 ]
Aldali, Hamzah J. [2 ]
Aldali, Rawand J. [3 ]
Aldali, Abdullah Z. [4 ]
Barayan, Mohammed A. [5 ]
机构
[1] Org Imam Mohammed Ibn Saud Islamic Univ, Pathol, Riyadh 13317, Saudi Arabia
[2] Univ Bristol, Coll Biomed Sci, Cellular & Mol Med, Bristol, Glos, England
[3] Univ West England, Forens Sci Dept Hlth & Appl Sci, Bristol, England
[4] Org Riyadh Care Hosp, Resp Therapy, Riyadh, Saudi Arabia
[5] Prince Sultan Mil Med City, Pathol Org, Riyadh 11159, Saudi Arabia
关键词
Polycystic Kidney disease; Kidney disease; Inherited Kidney disease; Case report;
D O I
10.54905/disssi/v26i128/ms409e2421
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This report presents a case report of a 29 year old Saudi Arabian patient who has been recently diagnosed with inherited polycystic kidney disease. The patient suffered from hypertensive symptoms and severe abdominal pain. Haematology, chemistry and microbiology examination was performed on the patient, alongside an ultrasound examination. The patient appeared to have hypertension, high uric acid and high lipid profile. The ultrasound results showed enlarged fatty liver, two cysts in the left liver (1.28cm and 1.32cm in width) and one cyst in the right liver (0.85cm in width). Currently, the patient's renal function is normal, but suffers from severe abdominal and kidney pain regularly, alongside hypertensive symptoms. The current treatments provided are Olmetec for controlling hypertension and intravenous analgesic such as xefo, morphine and paracetamol. There is currently no treatment for polycystic kidney disease. Therefore, patient is continuously monitored on a monthly basis.
引用
收藏
页数:5
相关论文
共 9 条
[1]   Pain patterns in patients with polycystic kidney disease [J].
Bajwa, ZH ;
Sial, KA ;
Malik, AB ;
Steinman, TI .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1561-1569
[2]  
Bleyer AJ, 2004, NEW ENGL J MED, V350, P2622
[3]   Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice [J].
Gansevoort, Ron T. ;
Arici, Mustafa ;
Benzing, Thomas ;
Birn, Henrik ;
Capasso, Giovambattista ;
Covic, Adrian ;
Devuyst, Olivier ;
Drechsler, Christiane ;
Eckardt, Kai-Uwe ;
Emma, Francesco ;
Knebelmann, Bertrand ;
Le Meur, Yannick ;
Massy, Ziad A. ;
Ong, Albert C. M. ;
Ortiz, Alberto ;
Schaefer, Franz ;
Torra, Roser ;
Vanholder, Raymond ;
Wiecek, Andrzej ;
Zoccali, Carmine ;
Van Biesen, Wim .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (03) :337-348
[4]  
Hergan B, 2018, GLOB IMAGINH INSIGHT, V2, P2, DOI [10.15761/GII.1000150, DOI 10.15761/GII.1000150]
[5]  
Masoumi Amirali, 2008, Ther Clin Risk Manag, V4, P393
[6]   Nephrolithiasis associated with autosomal dominant polycystic kidney disease: Contemporary urological management [J].
Ng, CS ;
Yost, A ;
Streem, SB .
JOURNAL OF UROLOGY, 2000, 163 (03) :726-729
[7]   Advances in the pathogenesis and treatment of polycystic kidney disease [J].
Patel, Vishal ;
Chowdhury, Renuka ;
Igarashi, Peter .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (02) :99-106
[8]   Epithelial transport in polycystic kidney disease [J].
Sullivan, LP ;
Wallace, DP ;
Grantham, JJ .
PHYSIOLOGICAL REVIEWS, 1998, 78 (04) :1165-1191
[9]   Clinical and pathological features of a neonate with autosomal recessive polycystic kidney disease caused by a nonsense PKHD1 mutation [J].
Zhou, Xi-Hui ;
Hui, Zhi-Yan ;
Li, Yuan .
WORLD JOURNAL OF PEDIATRICS, 2013, 9 (01) :76-79